|
|
 |
|
BDSI: Biodelivery Sciences Intl Inc - Stock News |
Enter Ticker:
|
|
| Nov 18, 2009 |
BioDelivery Sciences Down 29.1% Since SmarTrend's Sell Recommendation |
| Nov 12, 2009 |
BioDelivery Sciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference |
| Nov 08, 2009 |
BioDelivery Sciences Down 30.9% Since SmarTrend's Sell Recommendation |
| Oct 28, 2009 |
BioDelivery Sciences Down 32.1% Since SmarTrend's Sell Recommendation |
| Oct 22, 2009 |
BioDelivery Sciences Down 25.9% Since SmarTrend's Sell Recommendation |
| Oct 16, 2009 |
BioDelivery Sciences Down 13.9% Since SmarTrend's Sell Recommendation |
| Oct 15, 2009 |
8020m.com: 8020m.com Stock Research - BioTech Alerts for DNAD, APDN, BDSI |
| Oct 13, 2009 |
Meda Launches Onsolis(TM) (Fentanyl Buccal Soluble Film) for the Treatment of Breakthrough Cancer Pain in Opioid Tolerant Patients |
| Oct 08, 2009 |
25 Companies Already Committed to Present at the OneMedForum 2010Finance Conference |
| Oct 08, 2009 |
BioDelivery Sciences and Meda Launch ONSOLIS (fentanyl buccal soluble film) |
| Oct 07, 2009 |
BioDelivery Sciences Down 21.2% Since SmarTrend's Sell Recommendation |
| Oct 07, 2009 |
BiomedReports: News and FDA Updates for AVANIR (NASDAQ:AVNR), BioDelivery Sciences (Nasdaq:BDSI) |
| Oct 06, 2009 |
BDSI: $1.3M Grant from Walter Reed Army Institute for Bioral Amphotericin B |
| Oct 06, 2009 |
BioDelivery Sciences Receives $1.3 Million US Army Grant For Investigation of Bioral Amphotericin B in Topical Leishmaniasis |
| Oct 05, 2009 |
BioDelivery Sciences to Ring The NASDAQ Stock Market Opening Bell |
| |
| ZACKS COMMENTARY FOR BDSI |
|
|
|
Sponsored Links 
0.15